The year 2022 promises new business alliances in the cannabis trade ecosystem. Bearing testament to this global phenomenon, Lift&Co. Expo 2022, Canada’s No. 1 cannabis conference and trade show, is being held at the Metro Toronto Convention Centre from May 12-15, 2022. Global thought leaders, innovators, traders, and regulators of the cannabis ecosystem will assemble at the event to discuss, discover, and educate, surrounding the latest developments in this industry.
Cannabis companies and budding entrepreneurs are invited to participate in the event, which includes the new CannaVest North Investment Forum, designed to connect aspiring companies with…
To learn more, please visit https://liftexpo.ca/.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com